Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Baumgartner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Basic & Clinical Pharmacology & Toxicology|May 5, 2020
The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case reportMaxim Kuzin, Isabel Scharrer, Daniele Nolan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 29, 2026
Something is not nothing: Hair-tested substance use and cognitive functions in a large community sample of young adultsLukas Eggenberger, Clarissa Janousch, Lydia Johnson-Ferguson, et al.
Frontiers in Psychiatry|April 27, 2019
Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use SeverityMatthias Vonmoos, Christoph Eisenegger, Oliver G Bosch, et al.
Swiss Medical Weekly|September 13, 2020
The new remuneration system TARPSY in Swiss psychiatric hospitals: effects on length of stay and readmissions?Urs Hepp, Constanze Raim Gautier, Markus Baumgartner, et al.
Archives of Toxicology|April 14, 2024
Higher paracetamol levels are associated with elevated glucocorticoid concentrations in hair: findings from a large cohort of young adultsLydia Johnson-Ferguson, Lilly Shanahan, Michelle Loher, et al.
Praxis|August 16, 2016
[Not Available]Egemen Savaskan, Markus Baumgartner, Dan Georgescu, et al.
European Journal of Neurology|November 10, 2025
Reference-Group Adjusted Behavioural Dysfunction Questionnaire Score Discriminates Highly Behavioural-Variant Frontotemporal Dementia From Major Depressive Disorder and Alzheimer's Disease DementiaAnna Semenkova, Olivier Piguet, Andreas Johnen, et al.
Journal of Neurology|March 23, 2023
The Behavioural Dysfunction Questionnaire discriminates behavioural variant frontotemporal dementia from Alzheimer's disease dementia and major depressive disorderAnna Semenkova, Olivier Piguet, Andreas Johnen, et al.
Drug Testing and Analysis|June 18, 2023
The Society of Hair Testing consensus on general recommendations for hair testing and drugs of abuse testing in hairDonata Favretto, Gail Cooper, Maristela Andraus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Basic & Clinical Pharmacology & Toxicology|May 5, 2020
The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case reportMaxim Kuzin, Isabel Scharrer, Daniele Nolan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 29, 2026
Something is not nothing: Hair-tested substance use and cognitive functions in a large community sample of young adultsLukas Eggenberger, Clarissa Janousch, Lydia Johnson-Ferguson, et al.
Frontiers in Psychiatry|April 27, 2019
Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use SeverityMatthias Vonmoos, Christoph Eisenegger, Oliver G Bosch, et al.
Swiss Medical Weekly|September 13, 2020
The new remuneration system TARPSY in Swiss psychiatric hospitals: effects on length of stay and readmissions?Urs Hepp, Constanze Raim Gautier, Markus Baumgartner, et al.
Archives of Toxicology|April 14, 2024
Higher paracetamol levels are associated with elevated glucocorticoid concentrations in hair: findings from a large cohort of young adultsLydia Johnson-Ferguson, Lilly Shanahan, Michelle Loher, et al.
Praxis|August 16, 2016
[Not Available]Egemen Savaskan, Markus Baumgartner, Dan Georgescu, et al.
European Journal of Neurology|November 10, 2025
Reference-Group Adjusted Behavioural Dysfunction Questionnaire Score Discriminates Highly Behavioural-Variant Frontotemporal Dementia From Major Depressive Disorder and Alzheimer's Disease DementiaAnna Semenkova, Olivier Piguet, Andreas Johnen, et al.
Journal of Neurology|March 23, 2023
The Behavioural Dysfunction Questionnaire discriminates behavioural variant frontotemporal dementia from Alzheimer's disease dementia and major depressive disorderAnna Semenkova, Olivier Piguet, Andreas Johnen, et al.
Drug Testing and Analysis|June 18, 2023
The Society of Hair Testing consensus on general recommendations for hair testing and drugs of abuse testing in hairDonata Favretto, Gail Cooper, Maristela Andraus, et al.
Pageof 1